APA (7th ed.) Citation

Lim, Y. T., Williams, T. C., Langley, R. J., & Weir, E. (2024). Mepolizumab in children and adolescents with severe eosinophilic asthma not eligible for omalizumab: A single Center experience. Journal of Asthma, 61(8), 793. https://doi.org/10.1080/02770903.2024.2303767

Chicago Style (17th ed.) Citation

Lim, Y. T., T. C. Williams, R. J. Langley, and E. Weir. "Mepolizumab in Children and Adolescents with Severe Eosinophilic Asthma Not Eligible for Omalizumab: A Single Center Experience." Journal of Asthma 61, no. 8 (2024): 793. https://doi.org/10.1080/02770903.2024.2303767.

MLA (9th ed.) Citation

Lim, Y. T., et al. "Mepolizumab in Children and Adolescents with Severe Eosinophilic Asthma Not Eligible for Omalizumab: A Single Center Experience." Journal of Asthma, vol. 61, no. 8, 2024, p. 793, https://doi.org/10.1080/02770903.2024.2303767.